Mednow Inc

Healthcare CA MNOW

0.02CAD
0.00(0%)

Last update at 2024-02-13T14:30:00Z

Day Range

0.020.02

LowHigh

52 Week Range

0.010.70

LowHigh

Fundamentals

Previous Close 0.02
Market Cap0.52M
Volume0
P/E Ratio-
Dividend Yield-%
EBITDA-17.09115M
Revenue TTM41.57M
Revenue Per Share TTM1.93
Gross Profit TTM 2.78M
Diluted EPS TTM-1.22

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-07-31	2021-07-31	2020-07-31	2019-07-31	2018-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-07-31	2021-07-31	2020-07-31	2019-07-31	2018-07-31
Income before tax	-30.07186M	-8.95383M	-0.46950M	-	-
Minority interest	0.07M	-	-	-	-
Net income	-29.48292M	-8.95383M	-0.46950M	-	-
Selling general administrative	22.66M	9.21M	0.47M	-	-
Selling and marketing expenses	-	-	-	-	-
Gross profit	2.78M	-	-	-	-
Reconciled depreciation	1.76M	0.20M	0.00000M	-	-
Ebit	-21.44884M	-8.99859M	-0.46950M	-0.01162M	-0.01346M
Ebitda	-28.12347M	-8.75167M	-0.46950M	-	-
Depreciation and amortization	-	-	-	-	-
Non operating income net other	-	-	-	-	-
Operating income	-21.64076M	-8.99859M	-0.46950M	-	-
Other operating expenses	-	-	-	-	-
Interest expense	0.19M	0.00081M	0.00000M	0.00000M	0.00000M
Tax provision	-0.51596M	-	-	-	-
Interest income	0.16M	0.05M	0.00000M	-	-
Net interest income	-0.03016M	0.05M	0.00000M	-	-
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-0.51596M	-	-	-	-
Total revenue	16.64M	0.41M	0.00000M	-	-
Total operating expenses	38.28M	9.41M	0.47M	-	-
Cost of revenue	13.86M	-	-	-	-
Total other income expense net	-8.40095M	-0.00453M	-	-	-
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-29.55590M	-8.95383M	-0.46950M	-	-
Net income applicable to common shares	-29.55590M	-8.95383M	-0.46950M	-0.01162M	-0.01346M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2022-07-31	2021-07-31	2020-07-31	2019-07-31	2018-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-07-31	2021-07-31	2020-07-31	2019-07-31	2018-07-31
Total assets	18.13M	34.17M	5.54M	-	-
Intangible assets	2.18M	0.53M	0.22M	-	-
Earning assets	-	-	-	-	-
Other current assets	-	0.09M	-	-	-
Total liab	12.12M	1.68M	0.15M	-	-
Total stockholder equity	6.08M	32.49M	5.39M	-	-
Deferred long term liab	-	-	-	-	-
Other current liab	0.80M	-	-	-	-
Common stock	31.66M	31.66M	4.75M	0.00006M	0.00006M
Capital stock	31.66M	31.66M	4.75M	-	-
Retained earnings	-39.33544M	-9.85241M	-0.48785M	-0.01835M	-0.00673M
Other liab	0.42M	-	-	-	-
Good will	0.72M	-	-	-	-
Other assets	0.43M	-	-	-	-
Cash	4.97M	28.76M	5.26M	-	-
Cash and equivalents	-	-	-	-	-
Total current liabilities	8.55M	1.37M	0.15M	0.14M	0.00673M
Current deferred revenue	-	-	-	-	-
Net debt	-	-	-	-	-
Short term debt	-	-	-	-	-
Short long term debt	2.78M	-	-	-	-
Short long term debt total	-	-	-	-	-
Other stockholder equity	13.76M	10.68M	1.13M	-	-
Property plant equipment	6.32M	1.46M	-	-	-
Total current assets	8.49M	31.68M	5.32M	0.00006M	0.00006M
Long term investments	0.00000M	0.50M	0.00000M	-	-
Net tangible assets	3.18M	31.96M	5.17M	-0.13637M	-0.00667M
Short term investments	-	-	-	-	-
Net receivables	2.22M	2.28M	0.07M	-	-
Long term debt	0.03M	-	-	-	-
Inventory	0.97M	-	-	-	-
Accounts payable	2.41M	1.06M	0.01M	0.00385M	0.00135M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	-	-
Deferred long term asset charges	-	-	-	-	-
Non current assets total	9.65M	2.49M	0.22M	-	-
Capital lease obligations	4.30M	0.39M	0.00000M	-	-
Long term debt total	-	-	-	-	-

Breakdown	2022-07-31	2021-07-31	2020-07-31	2019-07-31	2018-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-07-31	2021-07-31	2020-07-31	2019-07-31	2018-07-31
Investments	-0.16000M	-0.50000M	-0.50000M	-0.50000M	-0.50000M
Change to liabilities	0.76M	0.62M	0.10M	0.00250M	0.00270M
Total cashflows from investing activities	-8.04063M	-3.58436M	-0.18547M	-0.11808M	-0.11808M
Net borrowings	0.34M	-0.00449M	-0.00449M	0.13M	0.01M
Total cash from financing activities	0.34M	32.68M	5.87M	0.13M	0.01M
Change to operating activities	0.08M	-0.83254M	-0.06839M	-0.06839M	-0.06839M
Net income	-29.55590M	-8.95383M	-0.46950M	-0.01162M	-0.01346M
Change in cash	-23.78807M	23.50M	5.26M	5.26M	0.00012M
Begin period cash flow	28.76M	5.26M	0.00006M	-	-
End period cash flow	4.97M	28.76M	5.26M	0.00006M	-
Total cash from operating activities	-16.08650M	-5.58833M	-0.43309M	-0.00912M	-0.01076M
Issuance of capital stock	0.00000M	33.55M	5.87M	-	-
Depreciation	1.31M	0.05M	0.05M	0.05M	0.05M
Other cashflows from investing activities	-0.78112M	-2.06960M	-0.08654M	-0.08654M	-0.08654M
Dividends paid	-	-	-	-	-
Change to inventory	0.02M	0.02M	0.02M	0.02M	-
Change to account receivables	-0.19491M	-0.19491M	-0.19491M	-0.19491M	-
Sale purchase of stock	-0.00012M	-0.86595M	-	-	-
Other cashflows from financing activities	-	-	-	-	-
Change to netincome	10.85M	3.38M	3.38M	3.38M	3.38M
Capital expenditures	1.59M	0.65M	0.65M	0.65M	0.65M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.86M	-0.21528M	0.04M	-	-
Stock based compensation	3.08M	3.37M	-	-	-
Other non cash items	0.56M	0.00081M	-	-	-
Free cash flow	-19.14323M	-6.60309M	-0.53202M	-	-

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
MNOW Mednow Inc	- -%	0.02	-	-	0.01	4.23	0.20	-0.3549
NURS Hydreight Technologies Inc	0.26 6.13%	4.50	406.00	25.91	7.85	20.38	7.45	109.02
RHT Reliq Health Technologies Inc	- -%	0.21	-	-	3.19	5.12	4.07	-10.7759
ADK Diagnos Inc	-0.005 2.17%	0.23	-	10.00	411.24	18.74	389.06	-6.1551
NXG NexgenRX Inc.	0.02 4.44%	0.47	39.00	32.68	1.55	4.64	1.39	7.84

Reports Covered

View All

Profile

Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. It also owns and operates retail pharmacies under the Mednow Pharmacy name located in the provinces of British Columbia and Ontario. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Mednow Inc

595 Howe St., Vancouver, BC, Canada, V6C 2T5

855-686-6300
https://www.mednow.ca

Key Executives

Name	Title	Year Born
Mr. Amir Ali Reyhany- Bozorg R.Ph.	Co-Founder, CEO & Chairman	1982
Mr. Felipe Campusano R.Ph.	Co-Founder, Treasurer, Corp. Sec. & Director	1973
Mr. Benjamin Ferdinand C.M.A., CPA, M.B.A.	Chief Financial Officer	NA
Simranveer Grewal	VP of Technology	NA
Ms. Lindsay Nahmiache	Member of Advisory Board - Marketing Advisor	NA
Mr. Anthony Perlman	Sr. VP of Benefits Strategy	NA
Mr. Dave Marantz	Chief Revenue Officer	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.